AT hook, DNA binding motif, containing 1 (DBSS) |
ZOLPIDEM |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
ZOLPIDEM |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
ZOLPIDEM |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
ZOLPIDEM |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
ZOLPIDEM |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
ZOLPIDEM |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
ZOLPIDEM |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
ZOLPIDEM |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
ZOLPIDEM |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
ZOLPIDEM |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
ZOLPIDEM |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
CLOXACILLIN |
Dopamine Transporter |
-16% |
NoneNone |
NoneNone |
View
|
dopamine receptor D1A |
CHLORZOXAZONE |
Dopamine D1 |
-16% |
NoneNone |
NoneNone |
View
|
dopamine receptor 2 |
EUGENOL |
Dopamine D2L |
-16% |
NoneNone |
NoneNone |
View
|
dopamine receptor 2 |
GUAIFENESIN |
Dopamine D2L |
-16% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
GLYCYRRHIZIN |
Cyclooxygenase COX-1 |
-16% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
GLYCYRRHIZIN |
Cyclooxygenase COX-1 |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
FLUNOXAPROFEN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
ALFACALCIDOL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
GLYBURIDE |
Progesterone |
-16% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
GLYBURIDE |
Progesterone |
-16% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, alpha polypeptide |
BETAMIPRON |
Platelet-Derived Growth Factor (PDGF) |
-16% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, alpha polypeptide |
BETAMIPRON |
Platelet-Derived Growth Factor (PDGF) |
-16% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, beta polypeptide |
BETAMIPRON |
Platelet-Derived Growth Factor (PDGF) |
-16% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, beta polypeptide |
BETAMIPRON |
Platelet-Derived Growth Factor (PDGF) |
-16% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, alpha polypeptide |
ANIRACETAM |
Platelet-Derived Growth Factor (PDGF) |
-16% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, alpha polypeptide |
ANIRACETAM |
Platelet-Derived Growth Factor (PDGF) |
-16% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, beta polypeptide |
ANIRACETAM |
Platelet-Derived Growth Factor (PDGF) |
-16% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, beta polypeptide |
ANIRACETAM |
Platelet-Derived Growth Factor (PDGF) |
-16% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
GLYCINE |
Phosphodiesterase PDE5 |
-16% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
GLYCINE |
Phosphodiesterase PDE5 |
-16% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
4-NONYLPHENOL |
Phosphodiesterase PDE3 |
-16% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
4-NONYLPHENOL |
Phosphodiesterase PDE3 |
-16% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
CITRIC ACID |
Phosphodiesterase PDE3 |
-16% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
CITRIC ACID |
Phosphodiesterase PDE3 |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
VINDESINE |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
VINDESINE |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
VINDESINE |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
VINDESINE |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
VINDESINE |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
VINDESINE |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
MANGANESE (II) CHLORIDE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
MANGANESE (II) CHLORIDE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
MANGANESE (II) CHLORIDE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
BROMOBENZENE |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
BROMOBENZENE |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
BROMOBENZENE |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
BROMOBENZENE |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
AMOXICILLIN |
Imidazoline I2, Central |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
AMOXICILLIN |
Imidazoline I2, Central |
-16% |
NoneNone |
NoneNone |
View
|
dopamine receptor 2 |
TRICHLOROACETIC ACID |
Dopamine D2L |
-16% |
NoneNone |
NoneNone |
View
|
dopamine receptor 2 |
BETA-NAPHTHOFLAVONE |
Dopamine D2L |
-16% |
NoneNone |
NoneNone |
View
|
dopamine receptor 2 |
DIDANOSINE |
Dopamine D2L |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
AMOXICILLIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
BETA-NAPHTHOFLAVONE |
CYP450-3A4 Inhibition |
-16% |
NoneNone |
NoneNone |
View
|
calcitonin receptor |
SULOCTIDIL |
Calcitonin |
-16% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
PHENOL |
CYP450-2C19 Inhibition |
-16% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
PHENOL |
Adrenergic, Norepinephrine Transporter |
-16% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
DIPYRONE |
Adrenergic, Norepinephrine Transporter |
-16% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
VINDESINE |
Vasoactive Intestinal Peptide VIP1 |
-16% |
NoneNone |
NoneNone |
View
|
Sigma-2 Receptor |
PHENACEMIDE |
Sigma2 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine receptor 6 |
ZOLPIDEM |
Serotonin 5-HT6 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
SULFAMETHAZINE |
Serotonin 5-HT3 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
SULFAMETHAZINE |
Serotonin 5-HT3 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
HYDROXYPROGESTERONE |
Serotonin 5-HT2C |
-16% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
KANAMYCIN |
Protein Tyrosine Kinase, HER2 Receptor |
-16% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
KANAMYCIN |
Protein Tyrosine Kinase, HER2 Receptor |
-16% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
GLYCYRRHIZIN |
Protein Tyrosine Kinase, Fyn |
-16% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
AMBROXOL |
Protein Tyrosine Kinase, Fyn |
-16% |
NoneNone |
NoneNone |
View
|
angiotensin 1 converting enzyme 1 |
METHAPYRILENE |
Protease, Angiotensin Converting Enzyme |
-16% |
NoneNone |
NoneNone |
View
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
METHAPYRILENE |
Protease, Angiotensin Converting Enzyme |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
DOXOFYLLINE |
Serotonin 5-HT4 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
DOXOFYLLINE |
Serotonin 5-HT4 |
-17% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
NIMESULIDE |
Protein Tyrosine Kinase, Fyn |
-17% |
NoneNone |
NoneNone |
View
|
bradykinin receptor B2 |
AZTREONAM |
Bradykinin B2 |
-17% |
NoneNone |
NoneNone |
View
|
bradykinin receptor, beta 2 |
AZTREONAM |
Bradykinin B2 |
-17% |
NoneNone |
NoneNone |
View
|
cathepsin G |
SPARFLOXACIN |
Protease, Cathepsin G |
-17% |
NoneNone |
NoneNone |
View
|
mast cell protease 9 |
SPARFLOXACIN |
Protease, Cathepsin G |
-17% |
NoneNone |
NoneNone |
View
|
histamine receptor H 1 |
SUXAMETHONIUM CHLORIDE |
Histamine H1, Central |
-17% |
NoneNone |
NoneNone |
View
|
dopamine receptor D4 |
CLOBETASOL PROPIONATE |
Dopamine D4.2 |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
CLINDAMYCIN |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
CLINDAMYCIN |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
CLINDAMYCIN |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
CLINDAMYCIN |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 4 polypeptide |
ATENOLOL |
ATPase, Na+/K+ |
-17% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
ATENOLOL |
ATPase, Na+/K+ |
-17% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
ATENOLOL |
ATPase, Na+/K+ |
-17% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
ATENOLOL |
ATPase, Na+/K+ |
-17% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
ATENOLOL |
ATPase, Na+/K+ |
-17% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 3 polypeptide |
ATENOLOL |
ATPase, Na+/K+ |
-17% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
ATENOLOL |
ATPase, Na+/K+ |
-17% |
NoneNone |
NoneNone |
View
|
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
ATENOLOL |
ATPase, Na+/K+ |
-17% |
NoneNone |
NoneNone |
View
|
angiotensin 1 converting enzyme 1 |
FAMOTIDINE |
Protease, Angiotensin Converting Enzyme |
-17% |
NoneNone |
NoneNone |
View
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
FAMOTIDINE |
Protease, Angiotensin Converting Enzyme |
-17% |
NoneNone |
NoneNone |
View
|
insulin receptor |
CHOLINE CHLORIDE |
Insulin |
-17% |
NoneNone |
NoneNone |
View
|
insulin receptor |
CHOLINE CHLORIDE |
Insulin |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
DANOFLOXACIN |
Serotonin 5-HT2A |
-17% |
NoneNone |
NoneNone |
View
|
adenosine A1 receptor |
3-AMINOBENZAMIDE |
Adenosine A1 |
-17% |
NoneNone |
NoneNone |
View
|
opioid receptor, sigma 1 |
ETHOSUXIMIDE |
Sigma1 |
-17% |
NoneNone |
NoneNone |
View
|
A3 adenosine receptor |
DOXAZOSIN |
Adenosine A3 |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
FLUCYTOSINE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
FLUCYTOSINE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
FLUCYTOSINE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
FLUCYTOSINE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
FLUCYTOSINE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
FLUCYTOSINE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
CHOLECALCIFEROL |
Thromboxane Synthetase |
-17% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
CHOLECALCIFEROL |
Thromboxane Synthetase |
-17% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
OXFENDAZOLE |
Chemokine CXCR1(IL-8A) |
-17% |
NoneNone |
NoneNone |
View
|
adenosine A1 receptor |
EMETINE |
Adenosine A1 |
-17% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
HOMATROPINE HYDROBROMIDE |
Vasoactive Intestinal Peptide VIP1 |
-17% |
NoneNone |
NoneNone |
View
|
interleukin 1 receptor, type I |
CIPROFLOXACIN |
Interleukin IL-1 alpha |
-17% |
NoneNone |
NoneNone |
View
|
histamine receptor H 1 |
ANTIMYCIN A |
Histamine H1, Central |
-17% |
NoneNone |
NoneNone |
View
|
histamine receptor H 1 |
TROGLITAZONE |
Histamine H1, Central |
-17% |
NoneNone |
NoneNone |
View
|
angiotensin II receptor, type 2 |
TROGLITAZONE |
Angiotensin AT2 |
-17% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
TROGLITAZONE |
Vasoactive Intestinal Peptide VIP1 |
-17% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 8 |
CHLORDIAZEPOXIDE |
Tumor Necrosis Factor (TNF), Non-Selective |
-17% |
NoneNone |
NoneNone |
View
|
melanocortin 5 receptor |
STANOZOLOL |
Melanocortin MC5 |
-17% |
NoneNone |
NoneNone |
View
|
calcitonin receptor |
SIBUTRAMINE |
Calcitonin |
-17% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
FLUOCINOLONE ACETONIDE |
CYP450-1A2 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
KITASAMYCIN |
CYP450-1A2 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|
opioid receptor, delta 1 |
PENICILLIN G |
Opiate delta |
-17% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
PENICILLIN G |
Cyclooxygenase COX-1 |
-17% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
PENICILLIN G |
Cyclooxygenase COX-1 |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
CHLORDIAZEPOXIDE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
CHLORDIAZEPOXIDE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
CHLORDIAZEPOXIDE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
CHLORDIAZEPOXIDE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
CHLORDIAZEPOXIDE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
CHLORDIAZEPOXIDE |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
CANDESARTAN |
Serotonin Transporter |
-17% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4A, cAMP specific |
PROPARACAINE |
Phosphodiesterase PDE4 |
-17% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4C, cAMP-specific |
PROPARACAINE |
Phosphodiesterase PDE4 |
-17% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4D |
PROPARACAINE |
Phosphodiesterase PDE4 |
-17% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4B, cAMP specific |
PROPARACAINE |
Phosphodiesterase PDE4 |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase D1 |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, theta |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, epsilon |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, gamma |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 beta |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|